v3.26.3
Restatement of Previously Issued Consolidated Financial Statements - Schedule of Consolidated Statement of Cash Flows (Details) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Schedule of Consolidated Statement of Cash Flows [Line Items]                
Net loss $ (692,584) $ (5,772,595) $ (2,955,849) $ (2,056,519) $ (6,465,179) $ (5,012,368) [1] $ (7,494,617) $ (9,826,283)
Depreciation, depletion, and amortization expense $ 2,136,209   458,190   3,927,185 555,265 [1] 3,170,092 2,407,098
Deferred income tax benefit         (2,119,384) (1,239,128) [1] 2,137,659 (3,470,407)
Accrued liabilities and other         1,032,756 1,809,667 [1] 4,935,434 3,018,930
Net cash provided by operating activities         $ 211,023 (2,296,949) [1] (7,645,418) $ 3,700,686
As Reported [Member]                
Schedule of Consolidated Statement of Cash Flows [Line Items]                
Net loss     (1,300,479) (1,752,231)     (10,126,617)  
Depreciation, depletion, and amortization expense             6,710,092  
Deferred income tax benefit           (1,169,130) 1,266,659  
Accrued liabilities and other             4,898,434  
Net cash provided by operating activities           (1,796,949) (7,645,418)  
Adjustments [Member]                
Schedule of Consolidated Statement of Cash Flows [Line Items]                
Net loss     $ (1,655,370) $ (304,288)     2,632,000  
Depreciation, depletion, and amortization expense             (3,540,000)  
Deferred income tax benefit           (69,998) 871,000  
Accrued liabilities and other             37,000  
Net cash provided by operating activities           $ (500,000)  
[1] As restated represents restatements previously disclosed in the Company's Form 10-K/A for the year ended December 31, 2025. See Note 11